Clinical trials
Technology clinical trials
Below are recruiting technology clinical trials, each written for real people, not researchers. We’re tracking 1,080 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07348471Recruiting
Gut bacteria transplant for ICU delirium
This study tests whether giving a transplant of healthy gut bacteria (called fecal microbiota transplantation) can help treat delirium in ICU patients. It may improve brain function by restoring gut health.
WuhanAges 18–80 - NCT06858358Recruiting
Robot vs. standard knee replacement for severe arthritis
This trial compares a robot-assisted knee replacement technique to the standard approach for people with severe knee arthritis. It aims to see which method leads to better recovery and outcomes.
Cluj-Napoca, ClujAges Any age - NCT07339332RecruitingEarly Phase 1
CAR-T cell therapy for moderate to severe lupus
This study tests whether a new CAR-T cell treatment (called CT1195E) can help people with lupus that hasn't improved with standard medicines. CAR-T cells are specially trained immune cells that seek out and destroy certain faulty immune cells, which may reduce lupus symptoms. The trial is for people with moderate to severe active lupus affecting organs like the kidneys, heart, or blood system.
Wuhan, HubeiAges 18–65 - NCT06852976RecruitingPhase 2
Gel treatment for diabetic foot ulcers study
This trial tests a new gel (MDI-1228-mesylate) applied to diabetic foot ulcers to see if it helps them heal faster than standard care alone. It is for people who have had a foot ulcer for at least 12 weeks and are already receiving standard treatment.
Durham, North CarolinaAges 18–75 - NCT07325162Recruiting
New eye scanner for cataract patients
This study is testing a new optical device that measures the eye before cataract surgery. It may help doctors get more accurate measurements for your lens implant.
Hilton Head Island, South CarolinaAges 18 years+ - NCT07327632RecruitingEarly Phase 1
Testing IBI3026 for advanced solid tumors
This study tests a new drug called IBI3026 for people with advanced solid tumors that cannot be surgically removed or have spread. The goal is to see if it is safe and helps control the cancer.
Chengdu, SichuanAges 18 years+ - NCT07326943Recruiting
Finding the Right Dose of Ropivacaine for Arm Surgery
This study is for people having hand or forearm surgery. It aims to find the smallest effective dose of a numbing medicine (ropivacaine) that works well to block pain during the procedure.
Taiyuan, ShanxiAges 18–60 - NCT07330882Enrolling by invitation
Heart health app study for coronary disease
This study tests a smartphone app to help people with coronary heart disease manage their health. You may be eligible if you have been diagnosed with coronary heart disease, can use a smartphone, and have no serious health issues that would limit exercise.
BengbuAges 18–80 - NCT07331363Recruiting
Robot ultrasound for breast cancer screening
This trial tests whether using a robot to perform breast ultrasound can help find cancer early. You would use a smartphone to guide the screening, and the study compares this method to standard screening.
Xiantao, HubeiAges 35–64 - NCT06156813Recruiting
Turkish lower limb movement log for stroke patients
This study aims to adapt a questionnaire that measures how well stroke survivors can use their legs in daily life. It may help doctors better understand your recovery and guide your rehabilitation.
GaziantepAges 18–80 - NCT07324304RecruitingPhase 2
DNA vaccine for liver cancer after curative surgery
This trial tests a DNA-based vaccine called NWRD06 to lower the risk of liver cancer returning after a curative surgery or ablation. It is for people with a specific protein on their cancer cells and good liver function.
Beijing, Beijing MunicipalityAges 18–65 - NCT07318675RecruitingPhase 1
Testing an ointment for actinic keratosis on the face
This trial tests an ointment called HW211026 for people with actinic keratosis, a common skin condition caused by sun damage. The study will check if the ointment is safe and works when applied to a 10 cm by 10 cm area on the face.
ShanghaiAges 18 years+ - NCT07317700RecruitingPhase 3
Study of a new pill for high-risk myelofibrosis
This trial is testing a new pill for people with intermediate or high-risk myelofibrosis, a type of bone marrow cancer. It aims to see if the drug can help manage the disease and offer a new treatment option for those who may have limited choices.
Chengdu, SichuanAges 18–80 - NCT07322367Recruiting
Mobile program to help you get screened for lung cancer
This study tests a mobile health program to remind and assist you in getting a lung cancer screening scan if you are at high risk. The goal is to make it easier to follow screening guidelines.
Winston-Salem, North CarolinaAges 50–77 - NCT07318246Recruiting
Teamwork and creative confidence in nursing students
This trial looks at how working in a team affects nursing students' belief in their own creativity. It might help you understand how teamwork builds creative confidence.
TaichungAges 18–65 - NCT07318298Recruiting
Hyaluronic acid injection for wisdom tooth socket healing
This trial tests if injecting hyaluronic acid into the sockets after wisdom tooth removal helps bone heal faster. It may be an option if you need both lower wisdom teeth removed and are generally healthy.
IrbidAges 18–35 - NCT07322198Enrolling by invitation
Gong's mobilization with scapular lift for frozen shoulder
This trial tests two types of physical therapy for frozen shoulder (adhesive capsulitis) to see which better improves shoulder movement and function. One therapy includes a special lift of the shoulder blade (scapular high lift), and the other does not.
Sialkot, Punjab ProvinceAges 40–60 - NCT07311369RecruitingPhase 2
Testing a new pain tablet after abdominal surgery
This trial tests a new pain tablet (HL-1186) for people having abdominal surgery. It aims to see if the tablet is safe and works well to manage pain after the operation.
Changsha, HunanAges 18–75 - NCT07310849Recruiting
Digital health support for older adults with diabetes
This study tests a digital care program using the LINE messaging app to help older adults with diabetes and other chronic conditions manage their health. It may be a good fit if you are 50 or older, have type 2 diabetes plus another condition like high blood pressure, and are comfortable using a smartphone.
New Taipei City, Wugu DistrictAges 50 years+ - NCT07314099Recruiting
Study of the Breizh Fabribus program for assistive devices
This study looks at the Breizh Fabribus program, which helps people get personalized assistive devices. It aims to see if the program helps improve your daily life.
Brest, FinistèreAges Any age - NCT07312058Recruiting
Fertility preservation after cancer: a long-term study
This study follows women who have had cancer or a blood disorder and chose to preserve their fertility before treatment. Researchers want to see how well these preservation methods work over time.
AmiensAges 18–47 - NCT07309900RecruitingPhase 1
Testing IASO208 for relapsed or hard-to-treat B-cell cancers
This trial tests a new treatment called IASO208 for people with certain types of B-cell lymphoma that have come back or not responded to standard treatments. It aims to see if the drug can help shrink tumors and control the cancer.
Wuhan, HubeiAges 18–75 - NCT06829212Recruiting
Wireless brain implant for device control
This trial tests a wireless brain implant that lets you control external devices like a computer or wheelchair just by thinking. It's designed for people with paralysis or double arm amputations who want to regain some independence.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07306117Enrolling by invitation
Digital oral health study for teens with gingivitis
This study tests a new digital tool to help teenagers with gum inflammation improve their oral health. It focuses on 16-17 year olds who have plaque on at least half of their teeth.
GothenburgAges 16–17
Hear when a new Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for technology?
- Yes. Clin2 currently lists 1,080 recruiting technology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a technology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a technology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.